Additionally, we found that KLHL37 also had a regulatory effect on C-Myc, and we suspect that this effect may contribute to the carcinogenic potential of KLHL37 in non-MYCN-amplified neuroblastoma as well as other tumors, which merits further investigation. The gene discussed is MYCN; the disease is neuroblastoma.